Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus

Vaccine

Volumn 15, Issue 6-7, 1997, Pages 597-602

  Tang, Yi Wei ^a,b   Neuzil, Kathleen M ^a   Fischer, Julie E ^a   Robinson, Frances W ^a   Parker, Robert A ^c   Graham, Barney S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

cytokine expression; respiratory syncytial virus; T cell subsets

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; INTERFERON PRODUCTION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; INTERFERON TYPE II; INTERLEUKIN-4; KINETICS; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; TUMOR CELLS, CULTURED; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 0031003252     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00214-9     Document Type: Article

References (30)

1. Hall, C.B. Prospects for a respiratory syncytial virus vaccine. Science 1994, 265, 1393-1394
2. Chin, J., Magoffin, R.L., Shearer, L.A., Schieble, J.H. and Lennette, E.H. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 1969, 89, 449-463
3. Fulginiti, V.A., Eller, J.J., Sieber, O.F., Joyner, J.W., Minamitani, M. and Meiklejohn, G. Respiratory virus immunization - a field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 1969, 89, 435-448
4. Kapikian, A.Z., Mitchell, R.H., Chanock, R.M., Shvedoff, R.A. and Stewart, C.E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 1969, 89, 405-421
5. Kim, H.W., Canchola, J.G. and Brandt, C.D. et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 1969, 89, 422-434
6. Belshe, R.B., Van Voris, L.P. and Mufson, M.A. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J. Infect. Dis. 1982, 145, 311-316
7. Kim, W.H., Arroio, J.O. and Pyles, G. et al. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Pediatrics 1971, 48, 745-755
8. Wright, P.F., Belshe, R.B., Kim, H.W., Van Voris, L.P. and Chanock, R.M. Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infect. Immun. 1982, 37, 397-405
9. Sadick, M.D., Locksley, R.M., Tubbs, C. and Raff, H.V. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. J. Immunol. 1986, 136, 655-661
10. Scott, P., Natovitz, R., Coffman, R.L., Pearce, E. and Sher, A. Immunization of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 1988, 168, 1675-1684
11. Güler, M.L., Gorham, J.D. and Hsieh, C.-S. et al. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 1996, 271, 984-987
12. Noben-Trauth, N., Kropf, P. and Müller, I. Susceptibility to Leishmania major infection in interteukin-4-deficient mice. Science 1996, 271, 987-990
13. Connors, M., Kulkarni, A.B. and Firestone, C.-Y. et al. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J. Virol. 1992, 66, 7441-7451
14. Graham, B.S., Bunton, L.A., Wright, P.F. and Karzon, DT. The role of T cell subsets in the pathogenesis of primary infection and reinfection with respiratory syncytial virus in mice. J. Clin. Invest. 1991, 88, 1026-1033
15. Alwan, W.H., Record, F.M. and Openshaw, P.J.M. Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. J. Immunol. 1993, 150, 5211-5218
16. Alwan, W.H., Kozlowska, W.J. and Openshaw, P.J. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 1994, 179, 81-89
17. Graham, B.S., Henderson, G.S., Tang, Y.-W., Lu, X., Neuzil, K.M. and Colley, D.G. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 1993, 151, 2032-2040
18. Graham, B.S. Immunologic determinants of RSV-induced disease. Trends Microbiol. 1996, 4, 290-293
19. Graham, B.S., Perkins, M.D., Wright, P.F. and Karzon, D.T. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 1988, 26, 153-162
20. Graham, B.S., Bunton, L.A., Wright, P.F. and Karzon, D.T. Reinfection of mice with respiratory syncytial virus. J. Med. Virol. 1991, 34, 7-13
21. Henderson, G.S., Conary, J.T., Davidson, J.M., Stewart, S.J., House, F.S. and McCurley, T.L. A reliable method for Northern blot analysis using synthetic oligonucleotide probes. Biotechniques 1991, 10, 190-197
22. Brun, A., Gaudernack, G. and Sandberg, S. A new method for the isolation of reticulocytes: positive selection of human reticulocytes by immunomagnetic separation. Blood 1990, 76, 2397-2403
23. Openshaw, P.J.M. Flow cytometric analysis of pulmonary lymphocytes from mice infected with respiratory syncytial virus. Clin. Exp. Immunol. 1989, 75, 324-328
24. Tang, Y.-W. and Graham, B.S. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest. 1994, 94, 1953-1958
25. Fujihashi, K., McGhee, J.R. and Beagley, K.W. et al. Cytokine-specific ELISPOT assay: single cell analysis of IL-2, IL-4 and IL-6 producing cells. J. Immunol. Meth. 1993, 160, 181-189
26. Street, N.E. and Mosmann, T.R. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 1991, 5, 171-177
27. Erard, F., Wild, MT., Garcia-Sanz, J.A. and Le Gros, G. Switch of CD8 T cells to noncytolytic CD8-CD4-cells that make TH2 cytokines and help B cells. Science 1993, 260, 1802-1805
28. Ferrick, D.A., Schrenzel, M.D., Mulvania, T., Hsieh, B., Ferlin, W.G. and Lepper, H. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 1995, 373, 255-257
29. Scharton, T.M. and Scott, P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 1993, 178, 567-577
30. Shankar, A.H. and Titus, R.G. T cell and non-T cell compartments can independently determine resistance to Leishmania major. J. Exp. Med. 1995, 181, 845-855